SAIC Wins Contract by JPEO-CBD
Science Applications International Corporation (SAIC) (NYSE: SAI) announced it was awarded a prime contract by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) to provide program, engineering, medical, and technical support services. The multiple-award indefinite-delivery/indefinite quantity contract has a three-year base period of performance, two one-year options, one six-month extension optional period, and a total contract value of $495 million for all awardees, if all options are exercised. Work will be performed in multiple cities throughout the continental United States and outside the continental United States.
JPEO-CBD provides research, development, acquisition, fielding and life-cycle support of chemical and biological defense equipment and medical countermeasures for the U.S. This includes the acquisition and fielding of chemical and biological detection and reconnaissance systems, individual and collective protection systems, decontamination systems, information management systems, medical devices, drugs and vaccines, and installation and force protection systems.
Under the contract, SAIC will provide support services to JPEO-CBD in several domains, including business and analytical; engineering and technical; logistics; information technology; and medical. SAIC is one of 42 contractors eligible to compete for task orders under the contract.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.